ABBV Operating cash flow
Operating cash flow at AbbVie rose to $19.0B in fiscal 2025, from $18.8B in 2024.
Net cash provided by operating activities, as filed.
SOURCE: us-gaap:NetCashProvidedByUsedInOperatingActivities · EDGAR CompanyFacts · CIK 1551152 · EDGAR ↗ · FY2021–FY2025 · ANNUAL
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Operating cash flow | Change |
|---|---|---|
| FY2025 | $19.0B | +$224M |
| FY2024 | $18.8B | $-4.0B |
| FY2023 | $22.8B | $-2.1B |
| FY2022 | $24.9B | +$2.2B |
| FY2021 | $22.8B | — |
Cross-checks touching this measure FROM THE FILING REVIEW
✓ MATCHESfull year results
Every quoted figure reconciles to the filed lines: $61.2 billion against total revenues; $15.1 billion against operating income; $2.36 against diluted earnings per share.
FY2025 10-K · FULL RECONCILIATION →◐ PARTLYoperating cash flow increase
The quote contains no checkable figures; the lines it references are shown, and nothing on this page confirms or contradicts it. The source sentence carries qualifiers beyond the 40-word quote limit; carried as partly supported.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANCash conversion stability
OCF ÷ NI ran 4.50× · 4.39× · 4.69× across three years — swing 0.30×, inside the 1.00× threshold.
FY2025 10-K · FULL RECONCILIATION →✓ CLEANCapital returned vs free cash flow
Capital returned ran 0.71× of free cash flow (threshold 1.00×).
FY2025 10-K · FULL RECONCILIATION →✓ CLEANStock compensation in cash flow
Share-based compensation is 5.0% of operating cash flow (threshold 15%).
FY2025 10-K · FULL RECONCILIATION →More SAME DATA, OTHER VIEWS
Operating cash flow across coverage → · ABBV company view →
Revenue · Net income · Free cash flow · Capital expenditure · Cash & equivalents · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.